Literature DB >> 8009099

Pulmonary cancer from the general practitioner's point of view. Experience from the health centre area of Kungsbacka, Sweden.

J Månsson1, C Bengtsson.   

Abstract

OBJECTIVE: To study the incidence of pulmonary cancer in a community with special reference to the diagnostic process and the role of the general practitioner.
DESIGN: Study of the records of all patients within the community with pulmonary cancer reported to the Swedish Cancer Registry during the years 1980-1984.
SETTING: The community of Kungsbacka in southwestern Sweden with about 48,000 inhabitants. PARTICIPANTS: 40 subjects with pulmonary cancer. OUTCOME MEASURES: Incidence, main symptoms, level of care, doctor delay, survival rate.
RESULTS: The incidence was 16 per 100,000 per year. Most patients first visited a general practitioner. Most common initial symptom was cough. Mean doctor delay was 12.5 weeks. The five-year mortality rate was 95%.
CONCLUSION: The high mortality emphasizes the importance of an early diagnosis. The general practitioners are very important in the diagnostic process.

Entities:  

Mesh:

Year:  1994        PMID: 8009099     DOI: 10.3109/02813439408997055

Source DB:  PubMed          Journal:  Scand J Prim Health Care        ISSN: 0281-3432            Impact factor:   2.581


  3 in total

1.  Characteristics and predictors of missed opportunities in lung cancer diagnosis: an electronic health record-based study.

Authors:  Hardeep Singh; Kamal Hirani; Himabindu Kadiyala; Olga Rudomiotov; Traber Davis; Myrna M Khan; Terry L Wahls
Journal:  J Clin Oncol       Date:  2010-06-07       Impact factor: 44.544

2.  Prolonged cough and lung cancer: the need for more general practice research to inform clinical decision-making.

Authors:  B M Liedekerken; A Hoogendam; F Buntinx; T van der Weyden; H C de Vet
Journal:  Br J Gen Pract       Date:  1997-08       Impact factor: 5.386

3.  What are the clinical features of lung cancer before the diagnosis is made? A population based case-control study.

Authors:  W Hamilton; T J Peters; A Round; D Sharp
Journal:  Thorax       Date:  2005-10-14       Impact factor: 9.139

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.